What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to disclose a press release issued by UnitedHealth Group on May 1, 2006, in compliance with Regulation FD. It serves as a notification that material information is being disseminated through this press release and potentially other oral or written communications.

Where can I find the detailed financial and operational information for UnitedHealth Group from around May 2006?

The substantive details of UnitedHealth Group's disclosures around this date would be contained within the press release filed as Exhibit 99 to this 8-K. For broader financial performance and operational updates, investors should consult the company's periodic reports such as their 10-Q (Quarterly Report) and 10-K (Annual Report) filed with the SEC around the same time.

What are some of the key risks mentioned in this filing that could impact UnitedHealth Group?

The filing highlights several key risks, including rising healthcare costs, increased competition, potential issues with the AARP contract, uncertainties in Medicare and Medicaid programs, litigation and regulatory scrutiny, challenges in contracting with providers, risks in the pharmacy benefits management sector, the need for effective information systems, potential impairment of intangible assets, and the successful integration of the PacifiCare acquisition.

Does this filing provide updated financial results?

This particular 8-K filing does not provide updated financial results directly within the report itself. Its primary function is to attach and announce the dissemination of a press release (Exhibit 99), which would contain any specific financial or operational updates intended for public release at that time.

UNH 8-K: Regulation FD

Summary

UnitedHealth Group Incorporated (UNH) filed an 8-K on May 1, 2006, primarily to disclose a press release dated May 1, 2006. The filing itself does not contain extensive new financial data but rather serves as a vehicle to disseminate information through the attached press release, in accordance with Regulation FD. Investors should note that this report is a notice of dissemination of a press release and not a filing with detailed operational or financial updates beyond what is contained in the exhibit. The press release likely contains the material information intended for public disclosure at that time, which would include any significant business developments, financial performance updates, or strategic announcements. It is crucial for investors to review the attached press release (Exhibit 99) for the substantive content of this filing.

Key Highlights

1The 8-K filing is primarily for Regulation FD disclosure, attaching a press release dated May 1, 2006.
2The filing serves as notice that UnitedHealth Group will make written and oral communications.
3The document lists significant risk factors that could affect the company's future performance, including healthcare cost increases, competition, AARP contract changes, Medicare/Medicaid uncertainties, litigation, and information system failures.
4Specific risks mentioned relate to the pharmacy benefits management industry and potential non-realization of benefits from the PacifiCare acquisition.
5The company explicitly states that forward-looking statements are subject to risks and uncertainties and that they do not undertake to publicly update them.
6Exhibit 99, the press release, is the key document containing the substantive information being disclosed.

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (May 1, 2006)

Summary

Key Highlights

Frequently Asked Questions